Balanced news tone
News Sentiment
HIMS sentiment intelligence
Hims Hers Health Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
86/100 classification confidence.
directly relevant articles
high-authority source matches
-6.6% over one week, +28.2% over four weeks, trend active, and materially above fair value.
A Look at Hims & Hers Health Inc (HIMS) After 5.8% Gain -- GF Va
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Hims & Hers Health, Inc. Class A Trade Ideas — BIVA:HIMS
This article compiles several trading ideas and analyses for Hims & Hers Health, Inc. (HIMS) from various traders on TradingView. It discusses potential technical patterns like inverse head and shoulders and mini head and shoulders, along with support and resistance levels, price
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 Jun 2026 15:40
- Source
- TradingView
Hims & Hers PAO Irene Becklund sells $370,518 in stock By Investing.com
Irene Becklund, Principal Accounting Officer at Hims & Hers Health, Inc. (NASDAQ:HIMS), sold shares totaling $370,518 in two transactions on June 16 and June 17, 2026. These sales were part of a pre-arranged trading plan and followed the vesting of Restricted Stock Units. The com
- Tone
- Negative 36/100
- Event
- Market update
- Published
- 18 Jun 2026 21:10
- Source
- Investing.com Nigeria
Hims & Hers (NYSE: HIMS) CEO exercises RSUs and withholds shares for taxes
Hims & Hers Health CEO Andrew Dudum exercised 154,991 Restricted Stock Units (RSUs) on June 15, 2026. To cover tax obligations related to this vesting, 85,632 shares were withheld by the company at $30.17 per share. Following these transactions, Dudum directly holds 957,043 share
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 20:09
- Source
- Stock Titan
HIMS (NYSE) Form 144: 12,500 and 11,226 vested Class A shares listed
Hims & Hers Health, Inc. (HIMS) has filed a Form 144 indicating proposed sales related to the vesting of Class A shares. The filing specifies two vesting events: 12,500 shares on March 15, 2026, and 11,226 shares on June 15, 2026. Fidelity Brokerage Services LLC is named as the b
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 19:02
- Source
- Stock Titan
Hims & Hers PAO Irene Becklund sells $370,518 in stock
Hims & Hers Health, Inc.'s Principal Accounting Officer, Irene Becklund, sold $370,518 worth of Class A Common Stock across two transactions in mid-June. These sales were executed under a pre-arranged trading plan, following the vesting of Restricted Stock Units. After these tran
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 09:09
- Source
- Investing.com
Hims & Hers CTO Mohamed Elshenawy sells $946,260 in stock
Hims & Hers Health, Inc. CTO Mohamed Elshenawy sold 30,040 shares of Class A Common Stock for $946,260 on June 17, 2026, as part of a Rule 10b5-1 trading plan. He also disposed of 151,534 shares worth $4,571,780 to cover tax obligations related to vested Restricted Stock Units (R
- Tone
- Negative 41/100
- Event
- Market update
- Published
- 18 Jun 2026 08:40
- Source
- Investing.com
Hims & Hers COO Michael Chi sells $441,850 in company stock
Michael Chi, COO of Hims & Hers Health, Inc., sold 14,027 shares of company stock worth $441,850 on June 17, 2026, under a pre-arranged trading plan. This sale followed his acquisition of 86,264 shares through RSU vesting, with a portion withheld for taxes. The company has also s
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 18 Jun 2026 03:10
- Source
- Investing.com
Hims & Hers (HIMS) exec nets shares after 32,919 RSU conversion
Hims & Hers Health, Inc. Chief Policy Officer Deborah M. Autor converted 32,919 Restricted Stock Units (RSUs) into Class A Common shares on June 15, 2026. After withholding 15,396 shares for tax obligations at $30.17 per share, she now directly holds 48,961 Class A Common shares.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 23:10
- Source
- Stock Titan
Hims & Hers (HIMS) CMO logs RSU vesting and tax share withholding
Hims & Hers Health Chief Medical Officer Patrick Harrison reported the vesting of 25,926 Restricted Stock Units (RSUs) on June 15, 2026. To cover tax obligations, 8,310 shares were withheld by the company, meaning no open-market sale occurred. Following these transactions, Harris
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 23:10
- Source
- Stock Titan
Hims & Hers (NYSE: HIMS) COO sells 14,027 shares, holds 432,124
Hims & Hers Health, Inc. COO Michael Chi sold 14,027 shares of Class A Common Stock at $31.50 per share under a pre-arranged Rule 10b5-1 trading plan. This transaction followed the exercise of 86,264 RSU awards and the withholding of 47,699 shares to cover tax obligations. After
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 23:10
- Source
- Stock Titan
Hims & Hers Health (HIMS) CTO exercises awards and sells 30,040 shares
Hims & Hers Health's CTO, Mohamed Elshenawy, exercised derivative awards for 282,597 shares and sold 30,040 shares at $31.50 each under a pre-arranged Rule 10b5-1 trading plan. The company also withheld 151,534 shares to cover tax obligations from RSU vesting. Following these tra
- Tone
- Negative 39/100
- Event
- Market update
- Published
- 17 Jun 2026 23:10
- Source
- Stock Titan
Lead Independent Director of Hims & Hers Health David Wells Buys 27% More Shares
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jun 2026 07:00
- Source
- simplywall.st
Hims earnings today: Why Hims & Hers Health stock dropped despite raising revenue forecast - here's what i
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 12 May 2026 07:00
- Source
- The Economic Times
Hims & Hers Health (HIMS) Margins Worsen As Q1 Loss Resurfaces And Tests Bullish Narratives
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 May 2026 07:00
- Source
- simplywall.st
Hims & Hers Health (HIMS) Valuation Check After Recent Share Price Pullback
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 May 2026 07:00
- Source
- Market source
Why Is Hims & Hers Health (HIMS) Stock Soaring Today
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Apr 2026 07:00
- Source
- Market source
Is Hims & Hers Health (HIMS) Pricing Reflect Fast-Growing Telehealth Hype Or Business Fundamentals
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Apr 2026 07:00
- Source
- simplywall.st
A Look Back at Health Insurance Providers Stocks’ Q4 Earnings: Alignment Healthcare (NASDAQ:ALHC) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 03 Apr 2026 07:00
- Source
- Market source
Hims & Hers Health, Regeneron, Biogen, BioMarin Pharmaceutical, and Moderna Shares Are Falling, What You Need To Know
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Apr 2026 07:00
- Source
- TradingView
Hims & Hers Health to acquire Australia's Eucalyptus for up to $1.15 billion
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Feb 2026 08:00
- Source
- Reuters
The Price Is Right For Hims & Hers Health, Inc. (NYSE:HIMS) Even After Diving 46%
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Feb 2026 08:00
- Source
- simplywall.st